Solid-organ transplantation specific organs

This edition includes two new chapters Documentation of Pharmacy Services, which addresses the critical need for pharmacists to record their medication therapy management interventions, and Solid-Organ Transplantation, which combines material that was previously spread throughout several organ-specific chapters. 

This chapter will examine the nephrotoxic potential of the cytokines or monoclonal antibodies at the doses being used in the treatment of cancer, autoimmune diseases, and transplantation. Non-specific inununomodulators and highly specific monoclonal antibodies are being used singly or in various combinations to treat cancer, autoimmune disease, and solid organ transplants. Many of these therapies achieve their effect by stimulahng the release of cytokines or release cytokines as a by-product of therapy. 

---